Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

NCT01358760 is registered in ClinicalTrials.gov with EndoCeutics Inc. as lead sponsor.

NCT NCT01358760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01358760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
Lead sponsor
EndoCeutics Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2011
Completion date
May 31, 2012
Enrollment
450 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal atrophy